0001213900-24-026824.txt : 20240327
0001213900-24-026824.hdr.sgml : 20240327
20240327212922
ACCESSION NUMBER: 0001213900-24-026824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolfe Lindsey
CENTRAL INDEX KEY: 0001650504
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40877
FILM NUMBER: 24793168
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERO THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001870404
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 871088814
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY
STREET 2: SUITE 230
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-407-2376
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY
STREET 2: SUITE 230
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: PHOENIX BIOTECH ACQUISITION CORP.
DATE OF NAME CHANGE: 20210630
4
1
ownership.xml
X0508
4
2024-03-25
0
0001870404
CERO THERAPEUTICS HOLDINGS, INC.
CERO
0001650504
Rolfe Lindsey
CERO THERAPEUTICS HOLDINGS, INC.
201 HASKINS WAY, SUITE 230
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Stock Option (Right to Buy)
1.77
2024-03-25
4
A
0
112500
0.00
A
2034-03-24
Common Stock
112500
112500
D
The shares underlying this option vest in thirty-six (36) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.
/s/ Charles Carter, Attorney-in-Fact
2024-03-27